
Opinion|Videos|August 15, 2023
Triplet Regimens for First-Line Advanced Renal Cell Carcinoma
Author(s)Rana R. McKay, MD
Discussion on triplet therapy regimens in advanced RCC and how progressing therapeutic studies can impact its future use.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5










































